首页> 外文期刊>Abdominal radiology. >White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI
【24h】

White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI

机译:腹阴放射学会的白皮书肝细胞癌肝癌诊断疾病的疾病专注于CT和MRI的LI-RADS V2018

获取原文
获取原文并翻译 | 示例
           

摘要

The Liver Imaging and Reporting Data System (LI-RADS) is a comprehensive system for standardizing the terminology, technique, interpretation, reporting, and data collection of liver imaging with the overarching goal of improving communication, clinical care, education, and research relating to patients at risk for or diagnosed with hepatocellular carcinoma (HCC). In 2018, the American Association for the Study of Liver Diseases (AASLD) integrated LI-RADS into its clinical practice guidance for the imaging-based diagnosis of HCC. The harmonization between the AASLD and LI-RADS diagnostic imaging criteria required minor modifications to the recently released LI-RADS v2017 guidelines, necessitating a LI-RADS v2018 update. This article provides an overview of the key changes included in LI-RADS v2018 as well as a look at the LI-RADS v2018 diagnostic algorithm and criteria, technical recommendations, and management suggestions. Substantive changes in LI-RADS v2018 are the removal of the requirement for visibility on antecedent surveillance ultrasound for LI-RADS 5 (LR-5) categorization of 10-19 mm observations with nonrim arterial phase hyper-enhancement and nonperipheral washout, and adoption of the Organ Procurement and Transplantation Network definition of threshold growth (50% size increase of a mass in 6 months). Nomenclatural changes in LI-RADS v2018 are the removal of -us and -g as LR-5 qualifiers.
机译:肝脏影像和报告数据系统(LI-RADS)是规范的术语,技术,解释,报告与全面的系统和肝成像改善通信,临床医疗,教育的首要目标的数据收集和研究患者风险或确诊为肝细胞癌(HCC)。在2018年,美国肝病研究学会(AASLD)集成LI-RADS成肝癌的基于成像诊断其临床实践指导。的AASLD和LI-RADS需要小的修改最近发布的LI-RADS v2017准则诊断成像标准,因此需要一个LI-RADS v2018更新之间的协调。本文提供了包含在LI-RADS的主要变化v2018,以及看看LI-RADS概述v2018的诊断方法和标准,技术建议和管理建议。在LI-RADS实质性变化v2018是用于对事前监控超声LI-RADS能见度去除的要求5(LR-5)与nonrim动脉相位超增强和非外围洗出,并通过10-19毫米的观察分类器官获取和阈值的增长(在6个月质量的50%大小的增加)的移植网络定义。在LI-RADS v2018是去除-us和-g作为LR-5限定符命名法的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号